Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 10:11:90.
doi: 10.1186/1471-2350-11-90.

Maternal angiotensinogen (AGT) haplotypes, fetal renin (REN) haplotypes and risk of preeclampsia; estimation of gene-gene interaction from family-triad data

Affiliations

Maternal angiotensinogen (AGT) haplotypes, fetal renin (REN) haplotypes and risk of preeclampsia; estimation of gene-gene interaction from family-triad data

Hege K Vefring et al. BMC Med Genet. .

Abstract

Background: Preeclampsia is a debilitating disorder affecting approximately 3% of pregnant women in the Western world. Although inconclusive, current evidence suggests that the renin-angiotensin system may be involved in hypertension. Therefore, our objective was to determine whether the genes for placental renin (REN) and maternal angiotensinogen (AGT) interact to influence the risk of preeclampsia.

Methods: Three haplotype-tagging SNPs (htSNPs) covering REN (rs5705, rs1464818, and rs3795575) and another three covering AGT (rs2148582, rs2478545 and rs943580) were genotyped in 99 mother-father-child triads of preeclampsia pregnancies. We estimated relative risks (RR) conferred by maternal AGT and fetal REN haplotypes using HAPLIN, a statistical software designed to detect multi-marker transmission distortion among triads. To assess a combined effect of maternal AGT and fetal REN haplotypes, the preeclamptic triads were first stratified by presence/absence of maternal AGT haplotype C-T-A and tested for an effect of fetal REN across these strata.

Results: We found evidence that mothers carrying the most frequent AGT haplotype, C-T-A, had a reduced risk of preeclampsia (RR of 0.4, 95% CI = 0.2-0.8 for heterozygotes and 0.6, 95% CI = 0.2-1.5 for homozygotes). Mothers homozygous for AGT haplotypes t-c-g and C-c-g appeared to have a higher risk, but only the former was statistically significant. We found only weak evidence of an overall effect of fetal REN haplotypes and no support for our hypothesis that an effect of REN depended on whether the mother carried the C-T-A haplotype of AGT (p = 0.33).

Conclusion: Our findings indicate that the mother's AGT haplotypes affect her risk for developing preeclampsia. However, this risk is not influenced by fetal REN haplotypes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Example of a typical REN (A) and AGT (B) threeplex reaction A. The SNaPshot result of a homozygous carrier of the most common REN haplotype, A-G-C (SNP order: rs5705, rs1464816 and rs3795575). B. The SNaPshot result of a patient carrying both the AGT haplotype C-T-A and haplotype t-c-g (SNP order: rs2148582, rs2478545 and rs943580). Lowercase denotes the minor allele at the locus and uppercase the major allele.

Similar articles

Cited by

References

    1. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science (New York, NY) 2005;308(5728):1592–1594. - PubMed
    1. Roberts JM. Endothelial dysfunction in preeclampsia. Seminars in reproductive endocrinology. 1998;16(1):5–15. doi: 10.1055/s-2007-1016248. - DOI - PubMed
    1. Roberts JM. Preeclampsia: what we know and what we do not know. Seminars in perinatology. 2000;24(1):24–28. doi: 10.1016/S0146-0005(00)80050-6. - DOI - PubMed
    1. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. BMJ (Clinical research ed) 1998;316(7141):1343–1347. - PMC - PubMed
    1. Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. BMJ (Clinical research ed) 2005;331(7521):877. doi: 10.1136/bmj.38555.462685.8F. - DOI - PMC - PubMed

Publication types

LinkOut - more resources